New Products: Direct Flow TAVR Systemn; Phillips TAVR Navigator; AliveCor AFib Detector
This article was originally published in The Gray Sheet
Executive Summary
Direct Flow has earned a CE Mark for the 23mm version of its transcatheter aortic heart valve system. FDA clears Phillips’ precision planning application for transcatheter valve implants. FDA approves an atrial fibrillation detection indication for AliveCor’s mobile phone-based heart monitor. More new product news.
You may also be interested in...
TAVR Evolution On Display At EuroPCR
Data on both new transcatheter aortic valve technologies and established TAVR devices were featured at this year’s EuroPCR meeting in Paris.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.